Co-Expression of Programmed Death-Ligand 1 (PD-L1) Expression in EGFR Mutant Stage IV Lung Adenocarcinoma

被引：0
|
作者：
Hsu, P. [1 ]
Wang, C. [2 ]
Kuo, S. [3 ]
Yang, C. [4 ]
机构：
[1] Chang Gung Med Fdn, Taoyuan, Taoyuan County, Taiwan
[2] Chang Gung Med Fdn, Dept Pathol, Taoyuan, Taoyuan County, Taiwan
[3] Chang Gung Med Fdn, Dept Thorac Med, Taoyuan, Taoyuan County, Taiwan
[4] Chang Gung Mem Hosp, Taoyuan, Taiwan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A7292
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Programmed Death-Ligand 1 Expression and EGFR Mutations in Multifocal Lung Cancer
    Haratake, Naoki
    Toyokawa, Gouji
    Takada, Kazuki
    Kozuma, Yuka
    Matsubara, Taichi
    Takamori, Shinkichi
    Akamine, Takaki
    Katsura, Masakazu
    Shoji, Fumihiro
    Okamoto, Tatsuro
    Oda, Yoshinao
    Maehara, Yoshihiko
    ANNALS OF THORACIC SURGERY, 2018, 105 (02): : 448 - 454
  • [42] Genomic correlates of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patients
    Li, Kang
    Liu, Jun
    Wu, Lin
    Xiao, Yajie
    Li, Jia
    Du, Haijian
    Zhao, Zhikun
    Sun, Chao
    Zhao, Yongtian
    Yang, Jie
    Wu, Dongfang
    Zhao, Zhuxiang
    Chen, Bolin
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [43] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN UTERINE GRADE 3 ENDOMETRIOID ADENOCANCER
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Guzel, A. B.
    Khatib, G.
    Seydaoglu, G.
    Vardar, M. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1126 - 1126
  • [44] Pathogenesis Analysis of Salivary Gland Tumors Through the Expression of Programmed Death-Ligand 1 (PD-L1)
    Aisyah Izzatul Muna
    Maria Evata Krismawati Surya
    Meiske Margaretha
    Jane Kosasih
    Mei Syafriadi
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2023, 75 : 3098 - 3102
  • [45] Evaluation of Programmed Death-Ligand 1 (PD-L1) Immunohistochemical Expression in Cytology Cell Block Preparations
    Hernandez, A.
    Brandler, T. C.
    Moreira, A.
    Schatz-Siemers, N.
    Simsir, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [46] Prognostic value of programmed death-ligand 1 (PD-L1) expression in ovarian clear cell carcinoma
    Zhu, Jun
    Wen, Hao
    Bi, Rui
    Wu, Yong
    Wu, Xiaohua
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2017, 28 (06)
  • [47] Pathogenesis Analysis of Salivary Gland Tumors Through the Expression of Programmed Death-Ligand 1 (PD-L1)
    Muna, Aisyah Izzatul
    Surya, Maria Evata Krismawati
    Margaretha, Meiske
    Kosasih, Jane
    Syafriadi, Mei
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2023, 75 (04) : 3098 - 3102
  • [48] The prevalence and clinicopathological features of programmed death-ligand 1 (PD-L1) expression: a pooled analysis of literatures
    Lin, Ziying
    Xu, Yutong
    Zhang, Yaxiong
    He, Qihua
    Zhang, Jianrong
    He, Jianxing
    Liang, Wenhua
    ONCOTARGET, 2016, 7 (12) : 15033 - 15046
  • [49] Programmed Death Ligand 1 (PD-L1) Expression in Primary Angiosarcoma
    Botti, Gerardo
    Scognamiglio, Giosue
    Marra, Laura
    Pizzolorusso, Antonio
    Di Bonito, Maurizio
    De Cecio, Rossella
    Cantile, Monica
    De Chiara, Annarosaria
    JOURNAL OF CANCER, 2017, 8 (16): : 3166 - 3172
  • [50] Programmed Death Ligand 1 (PD-L1) Expression in Cervical Cancer
    Lathika, Aryakrishna S.
    Lakshmi, S.
    Ramdas, Preethi T.
    Kumar, Aswin
    Mathews, Susan
    Joseph, John
    Mathew, Aleyamma
    James, Francis V.
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 19 (04)
12345